VMP 42135811000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Primidone 250mg tablets
BNF code 0408010U0AAABAB
Virtual Therapeutic Moiety Primidone
Date identifier became valid 4 Aug 2023
Previous product identifier 322948000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Primidone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 250.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Mysoline 250mg tablets (Necessity Supplies Ltd)
Primidone 250mg tablets (A A H Pharmaceuticals Ltd)
Primidone 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Primidone 250mg tablets (Aspire Pharma Ltd)
Primidone 250mg tablets (Drugsrus Ltd)
Primidone 250mg tablets (Medihealth (Northern) Ltd)
Primidone 250mg tablets (SERB)
Primidone 250mg tablets (Sigma Pharmaceuticals Plc)
Primidone 250mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Primidone 250mg tablets 100 tablet
Primidone 250mg tablets 30 tablet
Primidone 250mg tablets 60 tablet
Primidone 250mg tablets 90 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback